Literature DB >> 17161432

The effectiveness of a human patient simulator in the ATLS shock skills station.

Robert Allen Cherry1, Jack Williams, John George, Jameel Ali.   

Abstract

BACKGROUND: The use of simulation as a teaching adjunct in Advanced Trauma Life Support (ATLS) has not undergone rigorous psychometric testing. We hypothesized that an advanced, computer-controlled human patient simulator (HPS) would be a useful adjunct to the ATLS shock skills station.
MATERIALS AND METHODS: Forty-four PGY-1 residents enrolled in ATLS courses were randomized into control (CTL) and experimental (EXP) groups. All students took a shock-specific pre- and post-test multiple choice question examination (MCQE). The EXP group used the HPS in the shock skills station; the CTL group was taught in a traditional manner. All students participated in an experimental, shock-specific objective structured clinical examination (OSCE) session at the end and had their performance evaluated. The EXP group was asked to evaluate the teaching effectiveness of the shock skills station.
RESULTS: There were no statistically significant differences between the EXP and CTL groups with respect to the pre- and post-test MCQE or the change in scores. The groups were similar in their overall performance during the shock-specific OSCE. The EXP and CTL groups were equivalent with respect to shock recognition, identification of the type of shock, and ability to select the correct treatment plan. The shock skills station was rated from very good to excellent in 91% of the EXP group versus 63% in the CTL group. The EXP group rated the simulator most helpful in learning to analyze data from the monitors.
CONCLUSIONS: Use of an advanced HPS during the ATLS shock skills station was equivalent to traditional teaching scenarios based on psychometric testing. Students subjectively preferred the simulator as a teaching tool and found it most useful in learning how to integrate data from hemodynamic monitors into clinical decision making.

Entities:  

Mesh:

Year:  2006        PMID: 17161432     DOI: 10.1016/j.jss.2006.08.010

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Tried and true: self-regulation theory as a guiding framework for teaching parents diabetes education using human patient simulation.

Authors:  Susan Sullivan-Bolyai; Kimberly Johnson; Karen Cullen; Terry Hamm; Jean Bisordi; Kathleen Blaney; Laura Maguire; Gail Melkus
Journal:  ANS Adv Nurs Sci       Date:  2014 Oct-Dec       Impact factor: 1.824

Review 2.  Development and pilot testing of a parent education intervention for type 1 diabetes: parent education through simulation-diabetes.

Authors:  Susan Sullivan-Bolyai; Carol Bova; Mary Lee; Kimberly Johnson
Journal:  Diabetes Educ       Date:  2012-01-05       Impact factor: 2.140

3.  Part 12: Education, implementation, and teams: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Jasmeet Soar; Mary E Mancini; Farhan Bhanji; John E Billi; Jennifer Dennett; Judith Finn; Matthew Huei-Ming Ma; Gavin D Perkins; David L Rodgers; Mary Fran Hazinski; Ian Jacobs; Peter T Morley
Journal:  Resuscitation       Date:  2010-10       Impact factor: 5.262

Review 4.  Virtual reality training for improving the skills needed for performing surgery of the ear, nose or throat.

Authors:  Patorn Piromchai; Alex Avery; Malinee Laopaiboon; Gregor Kennedy; Stephen O'Leary
Journal:  Cochrane Database Syst Rev       Date:  2015-09-09

5.  Performance assessment using sensor technology.

Authors:  Hossein Mohamadipanah; Brett Wise; Anna Witt; Cassidi Goll; Su Yang; Calvin Perumalla; Kayla Huemer; LaDonna Kearse; Carla Pugh
Journal:  J Surg Oncol       Date:  2021-08       Impact factor: 2.885

Review 6.  Five Questions Critical Care Educators Should Ask About Simulation-Based Medical Education.

Authors:  Dominique Piquette; Vicki R LeBlanc
Journal:  Clin Chest Med       Date:  2015-06-26       Impact factor: 2.878

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.